Paradiem LLC Makes New Investment in Haleon PLC Sponsored ADR $HLN

Key Points

• Paradiem LLC has acquired a new position in Haleon PLC, purchasing 186,977 shares valued at approximately $1.94 million in the second quarter.
• Institutional investors increased their stakes in Haleon, with HB Wealth Management LLC raising its holdings by 47.2% and Hanson & Doremus Investment Management by 234.1% during the same period.
• Haleon announced a new semi-annual dividend of $0.0555 per share, a slight increase from the previous dividend, showcasing a healthy dividend payout ratio of 28.21%.

Paradiem LLC acquired a new position in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 186,977 shares of the company's stock, valued at approximately $1,939,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. HB Wealth Management LLC raised its holdings in Haleon by 47.2% during the 2nd quarter. HB Wealth Management LLC now owns 134,796 shares of the company's stock worth $1,398,000 after purchasing an additional 43,202 shares during the last quarter. Janney Montgomery Scott LLC raised its holdings in Haleon by 1.4% during the 2nd quarter. Janney Montgomery Scott LLC now owns 901,775 shares of the company's stock worth $9,351,000 after purchasing an additional 12,381 shares during the last quarter. Hanson & Doremus Investment Management raised its holdings in Haleon by 234.1% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company's stock worth $25,000 after purchasing an additional 1,662 shares during the last quarter. Signaturefd LLC raised its holdings in Haleon by 6.6% during the 2nd quarter. Signaturefd LLC now owns 148,322 shares of the company's stock worth $1,538,000 after purchasing an additional 9,187 shares during the last quarter. Finally, Kathmere Capital Management LLC raised its holdings in Haleon by 28.3% during the 2nd quarter. Kathmere Capital Management LLC now owns 84,743 shares of the company's stock worth $879,000 after purchasing an additional 18,673 shares during the last quarter. 6.67% of the stock is owned by institutional investors.

Haleon Stock Performance

Shares of HLN stock opened at $8.83 on Tuesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The stock has a 50-day moving average of $9.56 and a 200-day moving average of $10.11. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42. The stock has a market cap of $39.44 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 2.61 and a beta of 0.23.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were paid a dividend of $0.0555 per share. This represents a yield of 190.0%. The ex-dividend date of this dividend was Friday, August 15th. This is a positive change from Haleon's previous semi-annual dividend of $0.05. Haleon's dividend payout ratio (DPR) is currently 28.21%.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Wall Street Zen cut Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Barclays cut Haleon from an "overweight" rating to an "equal weight" rating in a research note on Tuesday, September 16th. Finally, The Goldman Sachs Group raised Haleon from a "neutral" rating to a "buy" rating in a research note on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and five have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Haleon presently has an average rating of "Moderate Buy" and an average target price of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.